These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2846463)

  • 1. Immune inhibition of virus release from herpes simplex virus-infected cells by human sera.
    Shariff DM; Hallworth J; Desperbasques M; Buchan A; Skinner GR
    Intervirology; 1988; 29(3):125-32. PubMed ID: 2846463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recurrent herpes in patients with different diseases of the internal organs].
    Khamaganova IV
    Ter Arkh; 1991; 63(10):154-6. PubMed ID: 1666694
    [No Abstract]   [Full Text] [Related]  

  • 3. The relative infrequency and low levels of neutralising and immunoprecipitating antibody to herpes simplex viruses types 1 and 2 in patients with a history of recurrent herpes genitalis.
    Woodman CB; Stocker D; Sugrue D; Desberbasques M; Hartley CE; Fuller A; Buchan A; Skinner GR
    Med Microbiol Immunol; 1983; 171(4):243-50. PubMed ID: 6304481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans.
    Douglas RG; Couch RB
    J Immunol; 1970 Feb; 104(2):289-95. PubMed ID: 4312871
    [No Abstract]   [Full Text] [Related]  

  • 5. Confirmation of herpes simplex virus type 2 infections in herpes-like genital lesions by a simple complement-fixation test.
    Arsenakis M; May JT
    Br J Vener Dis; 1982 Feb; 58(1):48-51. PubMed ID: 6275941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection.
    Sherlock CH; Ashley RL; Shurtleff ML; Mack KD; Corey L
    J Clin Microbiol; 1986 Dec; 24(6):1093-7. PubMed ID: 3023439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of acyclovir on antibody response to herpes simplex virus in primary genital herpetic infections.
    Bernstein DI; Lovett MA; Bryson YJ
    J Infect Dis; 1984 Jul; 150(1):7-13. PubMed ID: 6086772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recurrent herpes infections. Viral isolation and serological study].
    Suárez M; Saavedra T; Phillips OM; Contreras Mdel C
    Med Cutan Ibero Lat Am; 1983; 11(1):55-60. PubMed ID: 6308366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immune responses to Herpes simplex virus type 1 in recurrent herpes labialis: in vitro blastogenesis and cytotoxicity to infected cell line.
    Steele RW; Vincent MM; Hensen SA; Fuccillo DA; Chapa IA; Canales L
    J Infect Dis; 1975 May; 131(5):528-34. PubMed ID: 165245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to herpes-simplex virus in "normal" cerebrospinal fluid.
    Russell AS; Saertre A
    Lancet; 1976 Jan; 1(7950):654-5. PubMed ID: 54583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural history of recurrent facial-oral infection with herpes simplex virus.
    Bader C; Crumpacker CS; Schnipper LE; Ransil B; Clark JE; Arndt K; Freedberg IM
    J Infect Dis; 1978 Dec; 138(6):897-905. PubMed ID: 216753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shedding of infectious virus/antibody complexes from vesicular lesions of patients with recurrent herpes labialis.
    Daniels CA; LeGoff SG
    Lancet; 1975 Sep; 2(7934):524-8. PubMed ID: 51344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of type-specific antibody to herpes simplex virus type 1 and 2 in human sera by complement-fixation tests.
    Skinner GR; Hartley CH; Whitney JE
    Arch Virol; 1976; 50(4):323-33. PubMed ID: 179502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of staphylococcal protein A on complement-potentiated neutralization of herpes simplex virus and immune lysis of virus-infected cells.
    Austin RM; Daniels CA
    Infect Immun; 1975 Oct; 12(4):821-7. PubMed ID: 172447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of human antibody responses to primary genital herpes simplex virus infection.
    Kohl S; Adam E; Matson DO; Kaufman RH; Dreesman GR
    Intervirology; 1982; 18(3):164-8. PubMed ID: 6292130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to herpes simplex virus in patients with recurrent herpes labialis. II. Relationship between interferon production and cytotoxic responses.
    Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Ogra PL
    Pediatr Res; 1986 Sep; 20(9):905-8. PubMed ID: 3018660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses.
    Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Cohen E; Orsini F; Ogra PL
    Clin Exp Immunol; 1986 Dec; 66(3):507-15. PubMed ID: 2436840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement-requiring neutralizing antibody in guinea pigs with primary and recurrent genital herpes.
    Zheng ZM; Hsiung GD
    Proc Soc Exp Biol Med; 1984 Nov; 177(2):332-6. PubMed ID: 6091148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative titers of antibodies to individual polypeptide antigens of herpes simplex virus type 1 in human sera.
    Eberle R; Mou SW
    J Infect Dis; 1983 Sep; 148(3):436-44. PubMed ID: 6311910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Western Blot Analysis to microneutralization for the detection of type-specific herpes simplex virus antibodies.
    Bernstein DI; Garratty E; Lovett MA; Bryson YJ
    J Med Virol; 1985 Mar; 15(3):223-30. PubMed ID: 2984325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.